https://ersgenomics.com/ weekly 1.0 https://ersgenomics.com/about monthly 0.8 https://ersgenomics.com/licensing monthly 0.9 https://ersgenomics.com/science monthly 0.8 https://ersgenomics.com/team monthly 0.7 https://ersgenomics.com/news weekly 0.7 https://ersgenomics.com/press weekly 0.7 https://ersgenomics.com/knowledge monthly 0.6 https://ersgenomics.com/contact monthly 0.7 https://ersgenomics.com/privacy yearly 0.3 https://ersgenomics.com/terms yearly 0.3 https://ersgenomics.com/news/march-monthly-cut- 2026-03-24 monthly 0.6 https://ersgenomics.com/news/the-promise-of-xenotransplantation 2026-03-03 monthly 0.6 https://ersgenomics.com/news/ers-genomics-the-monthly-cut 2026-02-26 monthly 0.6 https://ersgenomics.com/press/ers-genomics-launches-new-early-access-express-license 2026-02-24 monthly 0.6 https://ersgenomics.com/news/crispr-and-more-delicious 2026-02-05 monthly 0.6 https://ersgenomics.com/news/10-years-of-ers-genomics 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-dyadic-applied-biosolutions-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/news/crispr-gpt-the-future-of-bioengineering 2026-02-05 monthly 0.6 https://ersgenomics.com/press/a-year-since-bio 2026-02-04 monthly 0.6 https://ersgenomics.com/press/cvc-successfully-appeals-prior-crispr-u-s-patent-decision 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ai-crispr-powering-the-21st-centurys-biological-revolution 2026-02-04 monthly 0.6 https://ersgenomics.com/news/licensee-case-study-bioneer 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-jumpcode-genomics-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/european-patent-office-grants-cvc-portfolio-key-crispr-patent 2026-02-05 monthly 0.6 https://ersgenomics.com/press/annual-letter-from-the-ceo 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-launches-express-license-platform-to-democratise-access-to-crispr-cas9 2026-02-05 monthly 0.6 https://ersgenomics.com/press/a-letter-from-the-ceo 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-universite-de-montreal-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/news/prime-editing 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-medicines-discovery-catapult-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/news/crispr-cas9-bioremediation 2026-02-05 monthly 0.6 https://ersgenomics.com/news/unlocking-the-power-of-prokaryotes 2026-02-05 monthly 0.6 https://ersgenomics.com/news/opening-pandoras-box 2026-02-05 monthly 0.6 https://ersgenomics.com/news/three-blind-mice 2026-02-05 monthly 0.6 https://ersgenomics.com/news/crispr-on-your-wrist 2026-02-05 monthly 0.6 https://ersgenomics.com/news/feathered-pharmaceuticals 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-irbm-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-appoints-john-e-milad-as-chief-executive-officer 2026-02-05 monthly 0.6 https://ersgenomics.com/press/key-charpentier-doudna-crispr-patent-upheld-by-china-national-intellectual-property-administration 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ricoh-and-ers-genomics-enter-into-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-stemsight-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/key-charpentier-doudna-crispr-patent-upheld-by-japanese-patent-office 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-limited-completes-licensing-agreement-with-chum-research-centre-montreal 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-limited-ers-completes-licensing-agreement-with-syngene-international 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-demeetra-enter-into-crispr-cas9-licensing-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-algenscribe-enter-into-crispr-cas9-licensing-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-santa-cruz-biotechnology-enter-into-crispr-cas9-licensing-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/https-ersgenomics-com-reflections-on-bio-international-boston-2023-reflections-on-bio-internatinoal 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-transomic-technologies-enter-into-crispr-cas9-licensing-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/manipulating-the-fabric-of-life 2026-02-04 monthly 0.6 https://ersgenomics.com/press/synbio-2023 2026-02-05 monthly 0.6 https://ersgenomics.com/press/new-crispr-cas9-license-agreement-for-ers-genomics-and-abm 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crisprcas9-prokaryotes 2026-02-04 monthly 0.6 https://ersgenomics.com/press/lspn-boston-2023-life-science-ip-review 2026-02-04 monthly 0.6 https://ersgenomics.com/news/bioremediation 2026-02-04 monthly 0.6 https://ersgenomics.com/press/bio-europe-basle-2023-our-thoughts 2026-02-04 monthly 0.6 https://ersgenomics.com/press/crispr-made-greener-products-and-processes-in-industrial-biotechnology 2026-02-04 monthly 0.6 https://ersgenomics.com/news/understanding-crisprcas9 2026-02-04 monthly 0.6 https://ersgenomics.com/news/base-editing 2026-02-04 monthly 0.6 https://ersgenomics.com/press/five-things-you-need-to-know-about-using-crispr-cas9-commercially 2026-02-04 monthly 0.6 https://ersgenomics.com/press/welcome-to-the-crispr-powerhouse 2026-02-05 monthly 0.6 https://ersgenomics.com/news/crispr-aquaculture 2026-02-04 monthly 0.6 https://ersgenomics.com/news/picking-the-right-crispr-system-for-your-research 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crisprcas9-yeast 2026-02-04 monthly 0.6 https://ersgenomics.com/news/do-you-need-a-license-to-use-crispr-in-drug-discovery-development-research 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crispr-the-switch-to-sustainable-cosmetics 2026-02-04 monthly 0.6 https://ersgenomics.com/news/livestock-factsheet 2026-02-04 monthly 0.6 https://ersgenomics.com/news/high-throughput-screening 2026-02-04 monthly 0.6 https://ersgenomics.com/news/patent-update 2026-02-04 monthly 0.6 https://ersgenomics.com/news/the-facts-about-crisprcas9-licensing 2026-02-04 monthly 0.6 https://ersgenomics.com/news/genome-modification 2026-02-04 monthly 0.6 https://ersgenomics.com/news/start-up-guide 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crispr-antibiotics 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crisprcas9-for-rapid-vaccine-development 2026-02-04 monthly 0.6 https://ersgenomics.com/news/whats-hot-in-synthetic-biology 2026-02-04 monthly 0.6 https://ersgenomics.com/news/crispr-animals 2026-02-04 monthly 0.6 https://ersgenomics.com/news/the-future-of-food 2026-02-04 monthly 0.6 https://ersgenomics.com/news/advancing-the-frontiers-of-biotherapeutics 2026-02-04 monthly 0.6 https://ersgenomics.com/press/foundational-crispr-cas9-gene-editing-patent-granted-to-cvc-in-canada 2026-02-05 monthly 0.6 https://ersgenomics.com/press/crown-bioscience-ers-genomics-announce-global-crispr-cas9-licensing-agreement-for-genome-editing-patents 2026-02-05 monthly 0.6 https://ersgenomics.com/press/new-crispr-cas9-license-agreement-for-ers-genomics-and-cosmo-bio 2026-02-05 monthly 0.6 https://ersgenomics.com/press/new-crispr-cas9-agreement-for-ers-genomics-and-atlatl 2026-02-05 monthly 0.6 https://ersgenomics.com/press/gene-editing-webinar-navigating-ip-deal-making-and-regulatory-challenges 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-lepton-pharmaceuticals-ltd-enter-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/new-crispr-cas9-license-agreement-for-ers-genomics-and-cytosurge 2026-02-05 monthly 0.6 https://ersgenomics.com/press/advances-for-india-as-foundational-crispr-cas9-gene-editing-patent-granted 2026-02-05 monthly 0.6 https://ersgenomics.com/press/patent-upheld-ers-leadership-position-in-european-crispr-landscape-confirmed 2026-02-05 monthly 0.6 https://ersgenomics.com/press/sumitomo-pharma-takes-license-to-crispr-cas9-patent-portfolio-from-ers-genomics 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-ciea-japan-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-crispr-interference-patent 2026-02-05 monthly 0.6 https://ersgenomics.com/press/new-hire-for-ers-genomics 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-china-new-patent 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-japan-slc-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-nippon-gene-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-genoway-enter-crispr-cas9-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/japanese-patent-office-upholds-key-charpentier-doudna-crispr-patent 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-genscript-biotech-corporation-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-nuvisan-icb-sign-crispr-cas9-license-agreement 2026-02-05 monthly 0.6 https://ersgenomics.com/news/ers-genomics-and-setsuro-tech-sign-crispr-cas9-license-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-licenses-crispr-gene-editing-technology-to-otsuka-pharmaceutical 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-expands-team-with-appointment-of-jon-kratochvil-as-vp-business-development 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-gflas-life-sciences-sign-crispr-cas9-license-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-zeclinics-sign-crispr-cas9-license-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/vivlion-gmbh-signs-worldwide-license-agreement-with-ers-genomics-for-crispr-cas9-patent-portfolio 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-announces-agreement-with-fasmac-to-commercialize-crispr-cas9-research-reagents-in-japan 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-congratulates-co-founder-emmanuelle-charpentier-on-receiving-the-2020-nobel-prize-in-chemistry 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-appoints-michael-arciero-as-vice-president-of-intellectual-property-commercial-development 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-announces-agreement-with-applied-stemcell-to-commercialize-crispr-gene-editing-services-and-reagents 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-provides-comment-on-us-patent-office-motions-decisions-in-crispr-cas9-interference-case 2026-02-04 monthly 0.6 https://ersgenomics.com/press/decision-on-motions-and-interference-redeclaration 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-axxam-announce-crispr-cas9-license-agreement-to-enhance-discovery-services 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-aelian-biotechnology-announce-crispr-cas9-license-agreement-enabling-aelians-unique-screening-platform 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-provides-comment-on-affirmation-of-key-crispr-cas9-patent-involved-in-european-opposition-proceedings 2026-02-05 monthly 0.6 https://ersgenomics.com/press/epo-technical-board-of-appeal-decision 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-provides-comment-on-epo-technical-board-of-appeal-decision-upholding-the-revocation-of-broad-institute-crispr-patent 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-licenses-crispr-gene-editing-technology-to-daiichi-sankyo-to-support-internal-research-and-development 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-announces-agreement-with-new-england-biolabs-to-commercialize-crispr-gene-editing-tools-and-reagents 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-provides-comment-on-new-patent-interference-with-the-broad-institute-relating-to-invention-of-the-crispr-cas9-system 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-licenses-crispr-gene-editing-technology-to-bioneer-to-further-advance-preclinical-disease-modelling 2026-02-04 monthly 0.6 https://ersgenomics.com/press/us-patent-office-grants-charpentier-doudna-key-crispr-patent 2026-02-04 monthly 0.6 https://ersgenomics.com/press/european-patent-office-grants-3rd-charpentier-doudna-patent-covering-uses-of-crispr-cas9-in-human-and-animals-cells 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-provides-comment-on-issuance-of-university-of-california-crispr-cas9-patent-including-uses-of-crispr-in-a-cell 2026-02-05 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-lonza-enter-into-crispr-cas9-technology-licensing-deal 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-licenses-crispr-gene-editing-technology-to-definigen-to-develop-human-cell-models-to-support-the-preclinical-development-of-therapeutics 2026-02-04 monthly 0.6 https://ersgenomics.com/press/u-s-patent-office-grants-second-charpentier-doudna-patent-covering-crispr-cas9-gene-editing 2026-02-04 monthly 0.6 https://ersgenomics.com/press/ers-genomics-and-syngulon-sign-license-agreement-on-crispr-cas9-genome-editing-patents-for-industrial-applications 2026-02-05 monthly 0.6 https://ersgenomics.com/press/genahead-bio-and-ers-genomics-enter-into-crispr-cas9-license-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/axcelead-drug-discovery-partners-and-ers-genomics-enter-into-crispr-cas9-license-agreement 2026-02-04 monthly 0.6 https://ersgenomics.com/press/u-s-appeals-court-upholds-patent-office-decision-and-delays-resolution-of-inventorship-for-crispr-cas9-gene-editing-technology 2026-02-04 monthly 0.6